BIONTECH : UBS sticks Neutral

marketscreener.com - 27 Nov 2023
Eliana Merle from UBS retains his Neutral opinion on the stock. The target price has been revised downwards and is now set at USD 110 as compared to USD 153 ...

BioNTech Takes Aim at Keytruda With Up to $950M Biotheus Buy

BioSpace - 13 Nov 2024
BioNTech Takes Aim at Keytruda With Up to $950M Biotheus Buy ...

BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition

Yahoo Finance - 13 Nov 2024
BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition ...

BioNTech signs agreement to acquire Biotheus

Pharmaceutical Technology - 14 Nov 2024
BioNTech signs agreement to acquire Biotheus ...

BioNTech Stock Got A IBD RS Rating Lift

Investor's Business Daily - 14 Nov 2024
BioNTech Stock Got A IBD RS Rating Lift ...

BioNTech Rings the Opening Bell

Nasdaq - 14 Nov 2024
BioNTech Rings the Opening Bell ...

BioNTech oncology acquisition to advance bispecific antibodies

European Pharmaceutical Review - 14 Nov 2024
BioNTech oncology acquisition to advance bispecific antibodies ...

The Analyst Landscape: 17 Takes On BioNTech

Benzinga - 14 Nov 2024
The Analyst Landscape: 17 Takes On BioNTech ...

BioNTech SE’s Strategic Growth in Oncology and mRNA

TipRanks - 14 Nov 2024
BioNTech SE’s Strategic Growth in Oncology and mRNA ...

Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17

News-Medical.Net - 12 Nov 2024
Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17 ...

BioNTech to acquire Chinese cancer drugmaker Biotheus for $800m

World Pharmaceutical Frontiers - 14 Nov 2024
BioNTech to acquire Chinese cancer drugmaker Biotheus for $800m ...

Comparing the COVID-19 Vaccines: How Are They Different?

Yale Medicine - 25 Oct 2024
Comparing the COVID-19 Vaccines: How Are They Different? ...

Germany’s BioNTech buys Biotheus in US$800 million push into cancer drugs

South China Morning Post - 14 Nov 2024
Germany’s BioNTech buys Biotheus in US$800 million push into cancer drugs ...

BioNTech to Report Q3 Earnings: Is a Beat in the Cards?

Yahoo Finance - 25 Oct 2024
BioNTech to Report Q3 Earnings: Is a Beat in the Cards? ...

BioNTech to Acquire Biotheus in $950 Million Deal

MarketWatch - 13 Nov 2024
BioNTech to Acquire Biotheus in $950 Million Deal ...

Friday Five – RFK Jr. nominated for HHS secretary, AbbVie faces schizophrenia setback, BioNTech and Merck buy into bispecifics race…and more

FirstWord Pharma - 15 Nov 2024
Friday Five – RFK Jr. nominated for HHS secretary, AbbVie faces schizophrenia setback, BioNTech and Merck buy into bispecifics race…and more ...

BioNTech